Northwest Biotherapeutics Correlations

NWBO Stock

USD 0.29 0.01 3.33%

The current 90-days correlation between Northwest Biotherapeutics and Valneva SE ADR is 0.03 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Northwest Biotherapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Northwest Biotherapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Northwest Biotherapeutics Correlation With Market

Significant diversification

The correlation between Northwest Biotherapeutics and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Northwest Biotherapeutics and DJI in the same portfolio, assuming nothing else is changed.

The ability to find closely correlated positions to Northwest Biotherapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Northwest Biotherapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Northwest Biotherapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Northwest Biotherapeutics to buy it.

Moving together with Northwest OTC Stock

0.64	DOMH	Dominari Holdings	Pair Corr
0.77	VINC	Vincerx Pharma	Pair Corr
0.65	CDTTW	Conduit Pharmaceuticals	Pair Corr

Moving against Northwest OTC Stock

0.77	DRUG	Bright Minds Biosciences	Pair Corr
0.61	SABSW	SAB Biotherapeutics	Pair Corr
0.56	VANI	Vivani Medical	Pair Corr
0.41	VCYT	Veracyte	Pair Corr
0.38	VCEL	Vericel Corp Ord	Pair Corr
0.38	VERA	Vera Therapeutics	Pair Corr
0.33	VERV	Verve Therapeutics	Pair Corr
0.71	VRNA	Verona Pharma PLC Buyout Trend	Pair Corr
0.54	VSTM	Verastem	Pair Corr
0.44	KTTAW	Pasithea Therapeutics	Pair Corr
0.39	VTVT	vTv Therapeutics	Pair Corr
0.33	DYAI	Dyadic International	Pair Corr

Related Correlations Analysis

	EQ	DMAC	VALN	VANI	DNLI	DNTH	DOMH	VCEL	VCNX	VCYT
EQ		-0.31	0.56	-0.18	0.18	0.51	0.37	-0.59	-0.17	-0.55	EQ
DMAC	-0.31		-0.72	0.46	-0.62	-0.39	-0.41	0.58	0.16	0.78	DMAC
VALN	0.56	-0.72		-0.64	0.71	0.74	0.75	-0.89	-0.03	-0.94	VALN
VANI	-0.18	0.46	-0.64		-0.43	-0.47	-0.67	0.73	0.35	0.68	VANI
DNLI	0.18	-0.62	0.71	-0.43		0.67	0.57	-0.47	0.2	-0.58	DNLI
DNTH	0.51	-0.39	0.74	-0.47	0.67		0.57	-0.72	-0.19	-0.66	DNTH
DOMH	0.37	-0.41	0.75	-0.67	0.57	0.57		-0.76	0.01	-0.71	DOMH
VCEL	-0.59	0.58	-0.89	0.73	-0.47	-0.72	-0.76		0.33	0.92	VCEL
VCNX	-0.17	0.16	-0.03	0.35	0.2	-0.19	0.01	0.33		0.23	VCNX
VCYT	-0.55	0.78	-0.94	0.68	-0.58	-0.66	-0.71	0.92	0.23		VCYT
	EQ	DMAC	VALN	VANI	DNLI	DNTH	DOMH	VCEL	VCNX	VCYT

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

VCYT	+ 0.92	VCEL
VCYT	+ 0.78	DMAC
DOMH	+ 0.75	VALN
DNTH	+ 0.74	VALN
VCEL	+ 0.73	VANI
DNLI	+ 0.71	VALN

High negative correlations

VCYT	- 0.94	VALN
VCEL	- 0.89	VALN
VCEL	- 0.76	DOMH
VCEL	- 0.72	DNTH
VALN	- 0.72	DMAC
VCYT	- 0.71	DOMH

Risk-Adjusted Indicators

There is a big difference between Northwest OTC Stock performing well and Northwest Biotherapeutics OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Northwest Biotherapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
EQ	4.18	(0.19)	0.00	(0.02)	0.00	0.00	13.33	(8.24)	64.12
DMAC	2.69	0.38	0.12	2.33	2.34	(3.25)	6.41	(3.85)	18.09
VALN	2.22	(0.83)	0.00	45.93	0.00	0.00	3.60	(6.16)	11.78
VANI	2.11	0.03	0.01	0.12	2.56	(2.52)	5.11	(4.24)	20.23
DNLI	2.43	(0.49)	0.00	(0.09)	0.00	0.00	6.73	(5.35)	22.00
DNTH	2.97	(0.28)	0.00	(0.14)	0.00	0.00	7.13	(6.74)	16.65
DOMH	2.58	(0.38)	0.00	(0.25)	0.00	0.00	6.41	(4.69)	23.01
VCEL	2.13	0.27	0.15	0.24	2.03	(2.62)	5.15	(3.52)	12.86
VCNX	6.55	(0.24)	0.00	(0.35)	0.00	0.00	11.52	(16.55)	54.95
VCYT	2.11	0.45	0.18	0.46	2.12	(2.26)	5.42	(3.60)	14.52

Be your own money manager

Our tools can tell you how much better you can do entering a position in Northwest Biotherapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Comparator Now

Portfolio Comparator

Compare the composition, asset allocations and performance of any two portfolios in your account

All Next

Launch Module

Northwest Biotherapeutics Corporate Management

Elected by the shareholders, the Northwest Biotherapeutics' board of directors comprises two types of representatives: Northwest Biotherapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Northwest. The board's role is to monitor Northwest Biotherapeutics' management team and ensure that shareholders' interests are well served. Northwest Biotherapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Northwest Biotherapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.

Leslie Goldman	Sr. VP of Bus. Devel.	Profile
Linda JD	CEO, Chairperson	Profile
David Innes	VP Relations	Profile
Jean Davis	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC